相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Use of non-steroidal anti-inflammatory drugs and risk of ischemic and hemorrhagic stroke in the Australian veteran community
Arduino A. Mangoni et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population
Marta L. Capone et al.
PHARMACOLOGICAL REPORTS (2010)
Use of disease risk scores in pharmacoepidemiologic studies
Patrick G. Arbogast et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2009)
Migraine and cardiovascular disease: systematic review and meta-analysis
Markus Schuerks et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke
Mendel D. M. Haag et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population
Luis Alberto Garcia Rodriguez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke
Christianne L. Roumie et al.
STROKE (2008)
Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data
Christianne L. Rournie et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Primer: administrative health databases in observational studies of drug effects - advantages and disadvantages
Samy Suissa et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
P. A. Scott et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident
N. S. Abraham et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's disease Anti-inflammatory Prevention Trial (ADAPT)
Barbara K. Martin et al.
PLOS CLINICAL TRIALS (2006)
Cardiovascular events associated with the use of four nonselective NSAIDs (Etodolac, Nabumetone, Ibuprofen, or Naproxen) versus a cyclooxygenase-2 inhibitor (Celecoxib): A population-based analysis in Taiwanese adults
Weng-Foung Huang et al.
CLINICAL THERAPEUTICS (2006)
Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase
Patricia McGettigan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke - A nested case-control study
Frank Andersohn et al.
STROKE (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Cardiovascular outcomes in new users of coxibs and nonsteroidal Antiinflammatory drugs -: High-risk subgroups and time course of risk
. Daniel H. Solomon et al.
ARTHRITIS AND RHEUMATISM (2006)
Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction
S Hernández-Díaz et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan - An observational study
WF Huang et al.
DRUG SAFETY (2006)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects
ML Capone et al.
CIRCULATION (2004)
Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery
E Ott et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)
Risk of stroke associated with nonsteroidal anti-inflammatory drugs -: A nested case-control study
S Bak et al.
STROKE (2003)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
